Horizon 2020

Eurotrials is interested in partnering with you in the Horizon 2020 Programme.

We are available in our areas of expertise, in the product development
strategy and in the implementation of clinical studies.

With research, technology and innovation at the core of Europe’s economy, the current European Framework Programme, Horizon 2020, presents itself as the biggest and most ambitious one to date. Through international collaboration, it has managed to shape the way research is done today.

In this evolving landscape, Eurotrials is able to support both national and international Research and Industry partners, providing our solid experience in clinical research and scientific consultancy, to accelerate translational research, support the development of new interventions and contribute to the improvement of patient outcomes through real world evidence.

– Maria João Queiroz, Global CEO

Type of Studies

Clinical Trials

Phase I, II, II, IV

Late Phase

Post Approval Effectiveness Studies

Post Approval Safety Studies

Post Marketing Observational

Health Economic and Outcome Research

Epidemology

Population / Disease Characterization

Clinical Practice Characterization

Disease Registry

Health Behavior Studies

Prevalence / Incidence

Product Registry

Validation Studies

Type of Services

Biosmiliar

Biotech

Cell Therapy products

Gene therapy products

Herbal products

Homeopathic products

Medical Devices

Other extractive products

Plasma derived products

Radiopharmaceutical products

Small molecule

Type of Products

R&D Consultancy

Clinical Research Methodology Consultancy

Feasibility Analysis

Study Design

Translational Research Studies

Implementation and Monitoring of Clinical Trials

Remote Monitoring & Risk-Based Monitoring

Observational Studies Design and Implementation

Data Management

Consultancy in Biostatistics

Medical Writing

Strategy & Regulatory Requirements Consultancy

Cosmetics, Functional Foods and Medical Devices

Pharmacovigilance

Health Economics

Quality

Teaching & Training

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

If you want to find out more, please visit Horizon 2020 Programme’s official web page, in this link.

Horizon 2020 calls for proposal associated to Eurotrials profiles:

 

Eurotrials:

SC1-PM-01-2016: Multi omics for personalised therapies addressing diseases of the immune system

SC1-PM-06-2016: Vaccine development for malaria and/or neglected infectious diseases

SC1-PM-08-2017: New therapies for rare diseases

SC1-PM-09-2016: New therapies for chronic diseases

SC1-PM-22-2016: Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America

 

Clinical Trials:

SC1-PM-05-2016: The European Human Biomonitoring Initiative

SC1-PM-08-2017: New therapies for rare diseases

SC1-PM-11-2016-2017: Clinical research on regenerative medicine

SC1-PM-22-2016: Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America

 

EPIS: Non-Interventional Pharmacoepidemiological Studies

SC1-PM-01-2016: Multi omics for personalised therapies addressing diseases of the immune system

SC1-PM-10-2017: Comparing the effectiveness of existing healthcare interventions in the adult population

 

EPIS: Epidemiological Research

SC1-PM-03-2017: Diagnostic characterisation of rare diseases

SC1-PM-04-2016: Networking and optimising the use of population and patient cohorts at EU level

SC1-PM-11-2016-2017: Clinical research on regenerative medicine

SC1-PM-22-2016: Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America

 

EPIS: Healtth Outcome Studies and Patient Reported Outcome Research

SC1-PM-15-2017: Personalised coaching for well-being and care of people as they age

Gonçalo Queiroz

Incentives & Market Research

Tel: (351) 213 825 440

E-mail: goncalo.queiroz@eurotrials.com